These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4300740)

  • 1. Homotypic and heterotypic antibody response in infants to adenovirus vaccine.
    van der Veen J; van Zaane DJ; Sprangers MA; Heyen CF
    Arch Gesamte Virusforsch; 1967; 21(3):320-33. PubMed ID: 4300740
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of live, oral types 1, 2, and 5 adenovirus vaccines.
    Schwartz AR; Togo Y; Hornick RB
    Am Rev Respir Dis; 1974 Feb; 109(2):233-9. PubMed ID: 4359736
    [No Abstract]   [Full Text] [Related]  

  • 3. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development.
    Green KY; Taniguchi K; Mackow ER; Kapikian AZ
    J Infect Dis; 1990 Apr; 161(4):667-79. PubMed ID: 2156942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J; Abarbanel MF; Oei KG
    Antonie Van Leeuwenhoek; 1969; 35(2):239. PubMed ID: 4316421
    [No Abstract]   [Full Text] [Related]  

  • 5. HETEROTYPIC HEMAGGLUTINATION-INHIBITION ANTIBODY RESPONSES IN VOLUNTEERS INOCULATED WITH ADENOVIRUS TYPES 26 AND 27.
    KASEL JA; KNIGHT V; ALLING DW
    J Immunol; 1964 Jun; 92():934-40. PubMed ID: 14210802
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J; Abarbanel MF; Oei KG
    J Hyg (Lond); 1968 Dec; 66(4):499-511. PubMed ID: 4303951
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types.
    Gooch WM; Mogabgab WJ
    Arch Environ Health; 1972 Dec; 25(6):388-94. PubMed ID: 4343867
    [No Abstract]   [Full Text] [Related]  

  • 8. IMMUNIZATION OF VOLUNTEERS WITH SOLUBLE ANTIGENS OF ADENOVIRUS TYPE 1.
    KASEL JA; HUBER M; LODA F; BANKS PA; KNIGHT V
    Proc Soc Exp Biol Med; 1964 Oct; 117():186-90. PubMed ID: 14219941
    [No Abstract]   [Full Text] [Related]  

  • 9. Beneficial use of inactivated porcine adenovirus vaccine and antibody response of young pigs.
    Kadoi K
    New Microbiol; 1997 Jan; 20(1):89-91. PubMed ID: 9037675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection.
    Gutekunst RR; White RJ; Edmondson WP; Chanock RM
    Am J Epidemiol; 1967 Sep; 86(2):341-9. PubMed ID: 4293744
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.
    Top FH; Buescher EL; Bancroft WH; Russell PK
    J Infect Dis; 1971 Aug; 124(2):155-60. PubMed ID: 4330998
    [No Abstract]   [Full Text] [Related]  

  • 12. [Successive multiple immunization with adenoviruses].
    Wigand R; Kho JT
    Z Med Mikrobiol Immunol; 1970; 156(1):115-24. PubMed ID: 4320671
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenovirus soluble antigen vaccine studies. I. Preparation and testing of adenovirus type 5 soluble antigen vaccines.
    Metzgar DP; Thomas WJ; Insalaco CS; DeSanctis AN; Beiler JM
    Proc Soc Exp Biol Med; 1968 Jul; 128(3):679-83. PubMed ID: 5668108
    [No Abstract]   [Full Text] [Related]  

  • 14. Live vaccines against influenza, adenoviruses, measles, and mumps.
    Smorodintsev AA; Alexandrova GI; Boychuck LM; Nasibov MN; Selivanov AA; Taros LY
    Arch Environ Health; 1969 Jan; 18(1):105-14. PubMed ID: 4302157
    [No Abstract]   [Full Text] [Related]  

  • 15. Concurrent administration of live adenovirus, type 4 and live Poliovirus, type 1 vaccines.
    Chin J; Lennette EH; Schieble JH; Magoffin RL
    Am J Epidemiol; 1968 May; 87(3):633-42. PubMed ID: 5654951
    [No Abstract]   [Full Text] [Related]  

  • 16. [HETEROLOGOUS ANTIBODY FORMATION AFTER IMMUNIZATION WITH POLIOMYELITIS VIRUSES].
    GOETZ O; OHRT B
    Klin Wochenschr; 1964 Dec; 42():1192-5. PubMed ID: 14339431
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.
    Top FH; Grossman RA; Bartelloni PJ; Segal HE; Dudding BA; Russell PK; Buescher EL
    J Infect Dis; 1971 Aug; 124(2):148-54. PubMed ID: 4330997
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses.
    Smith TJ; Buescher EL; Top FH; Altemeier WA; McCown JM
    J Infect Dis; 1970 Oct; 122(4):239-48. PubMed ID: 4323443
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody response to modified-live canine adenovirus vaccine in African hunting dogs (Lycaon pictus).
    Spencer JA
    Zentralbl Veterinarmed B; 1991 Aug; 38(6):477-9. PubMed ID: 1659069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against adenovirus infections.
    van der Veen J
    Maandschr Kindergeneeskd; 1968 Nov; 36(7):212-7. PubMed ID: 4304545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.